Results 71 to 80 of about 67,833 (224)
Ebola virus disease: past, present and future
Ebola virus disease is one of the most deadly ailments known to mankind due to its high mortality rate (up to 90%) accompanying with the disease. Ebola haemorrhagic fever (EHF) is an infectious disease of animal that can be transmitted to both human and ...
Harish Rajak +4 more
doaj +1 more source
IntroductionIn the absence of clinical efficacy data, vaccine protective effect can be extrapolated from animals to humans, using an immunological biomarker in humans that correlates with protection in animals, in a statistical approach called ...
Chelsea McLean +19 more
doaj +1 more source
Survey on Visualization of Information Diffusion over Networks
Abstract Information Diffusion (ID) describes how a value (e.g., a pathogen, a rumor, a packet) spreads through an underlying “medium” network of elements (e.g., a social or computer network). Understanding the information diffusion process is essential to predicting trends, controlling misinformation, and enhancing decision‐making as well as ...
T. Baumgartl +8 more
wiley +1 more source
ABSTRACT COVID‐19 intensified ethical tensions between clinicians' duty to care and self‐protection amid PPE shortages. We explored frontline healthcare professionals' perspectives in Maputo, Mozambique. Semi‐structured interviews with healthcare professionals at four hospitals (April–June 2022) were recorded in Portuguese, transcribed, and ...
Ângela Alface +5 more
wiley +1 more source
Resposta davant de l’epidèmia de malaltia pel virus Ebola a l’Àfrica Occidental (2014-2015): lliçons apreses en el nostre entorn [PDF]
Virus Ebola; Àfrica Occidental; EpidemiaVirus Ebola; África Occidental; EpidemiaEbola virus; West Africa; EpidemicEl propòsit d’ aquest informe és fer una valoració dels aspectes més destacats de la gestió de l’epidèmia en el nostre entorn i poder fer ...
Comitè Científic Assessor de la Malaltia per Virus Ebola
core
Recombinant modified vaccinia virus Ankara generating Ebola virus-like particles [PDF]
There are currently no approved therapeutics or vaccines to treat or protect against the severe hemorrhagic fever and death caused by Ebola virus (EBOV). Ebola virus-like particles (EBOV VLPs) consisting of the matrix protein VP40, the glycoprotein (GP),
Wolferstätter, Michael +27 more
core +1 more source
ABSTRACT Aim To synthesise evidence on wearable devices for continuous vital signs monitoring in adult hospital inpatients, focusing on clinical effectiveness, nursing perspectives, workflow impact, patient experience and resource implications. Design Scoping review.
Sian Myfanwy Shaw +2 more
wiley +1 more source
Insectary‐reared mosquitoes were simultaneously assessed for species identification, bloodmeal source analysis and Plasmodium detection, using a single multiplexed sequencing run on the MinION sequencing platform. The method was applied to 150 insectary‐reared mosquitoes, representing nine species blood‐fed with five vertebrate hosts and 40 samples for
E. Abby Rogers +5 more
wiley +1 more source
Virus-Vectored Ebola Vaccines [PDF]
The Ebola virus disease (EVD) is one of the most dangerous infections affecting humans and animals. The first EVD outbreaks occurred in 1976 in Sudan and Zaire. Since then, more than 20 outbreaks have occurred; the largest of which (2014-2016) evolved into an epidemic in West Africa and claimed the lives of more than 11,000 people. Although vaccination
I V, Dolzhikova +13 more
openaire +2 more sources
BackgroundUganda has reported five (5) Ebola virus disease outbreaks and three (3) Marburg virus disease outbreaks from 2000 to 2016. Peoples' knowledge and attitude towards Ebola and Marburg virus disease impact on control and prevention measures ...
Luke Nyakarahuka +9 more
doaj +1 more source

